FDA inspection
Amgen Europe BV: FDA inspection ending Jan 11, 2018
FDA inspection 1041358 · No Action Indicated (NAI) · Breda
Key facts
| Inspection ID | 1041358 |
|---|---|
| Firm | Amgen Europe BV |
| FEI number | 3005889661 |
| Address | Minervum 7061, Postbus 3345 |
| City | Breda |
| Country | Netherlands |
| Fiscal year | 2018 |
| Inspection end date | Jan 11, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data